38 research outputs found

    Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

    Get PDF
    Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involving kinases, we found 1,275 with an intact kinase domain, the proportion of which varied significantly across cancer types. Our study suggests that fusions drive the development of 16.5% of cancer cases and function as the sole driver in more than 1% of them. Finally, we identified druggable fusions involving genes such as TMPRSS2, RET, FGFR3, ALK, and ESR1 in 6.0% of cases, and we predicted immunogenic peptides, suggesting that fusions may provide leads for targeted drug and immune therapy

    Kansas Swine Improvement Association Testing Station

    No full text
    The seventh group of pigs tested in the Kansas Swine Testing Station completed their test during the 1961-62 winter. The Animal Husbandry Department and the Extension Service cooperation in manging and supervising the station. All expenses incurred in testing are paid by breeders or producers who have pigs tested

    Kansas Swine Improvement Association testing station

    No full text
    Eleven Kansas swine produces had 27 pens of barrows and gilts on test during the summer of 1963. It was necessary to send most of the pigs to Maurer-Neuer Meat Packers in Arkansas City for slaughter because our refrigeration facilities failed. Some carcass data were lost. Table 28 summarizes performance and carcass data collected
    corecore